SHIFT

Systolic Heart failure treatment with the If inhibitor ivabradine Trial

Stage: klaar
Medicine: ivabradine
Population: Hartfalen
Phase: III
First Patient In: 1 January 2006
Last Patient In: -
Last Patient Last Visit: -

Study Director

dr. T. Lenderink

Cardioloog